Your daily dose of news and tidbits from the world of money in politics:

COMPROMISE ON HORIZON FOR DODD, FINANCIAL BILL? U.S. Sen. U.S. Sen. Chris Dodd (D-Conn.) spent months railing against the Federal Reserve for what he considered its failure to protect consumers from abusive financial institutions.

Potentially in the offing: A bipartisan bill, crafted in part with Sen. Bob Corker (R-Tenn.), that the Washington Post‘s Binyamin Appelbaum and David Cho report would “place a presidential appointee inside the Fed with an independent budget and a mandate to write rules protecting consumers. Those rules, however, would be enforced by existing banking regulators.”

Capital Eye series, “ Read our recent coverage of Dodd’s role in national financial reform here . And for full coverage of the money-in-politics angles of financial reform, read our recentseries, “ Crossing Wall Street .”

Whew.

Writes Ford: “The cruel twist, of course, is that the party bosses who tried to intimidate me so that I wouldn’t even think about running against Senator Kirsten Gillibrand … are the same people responsible for putting Democratic control of the Senate at risk.”

Had Ford run against Gillibrand, he would have likely done so with strong backing from financial institutions, labor unions and law firms, all his historical backers . During his years in the House that led to his 2006 Senate bid, Ford raised more than $19.2 million — an impressive sum by any account.

Would Ford rule out running at some point in the future? That’s unclear. “I’m a Democrat,” he said in his op-ed article. “But I am an independent Democrat.”

A NEW OPENSECRETS.ORG LOBBYING TOOL: If you’re a frequent user of our Have a news tip or link to pass along? We want to hear from you! E-mail us at [email protected] If you’re a frequent user of our lobbying database , you may have noticed a subtle change with great utility. Within our industry profiles, users may sort lobbying clients both by name and the amount the clients spent on federal lobbying. This is particularly useful when all you need is a quick, at-a-glance look at who the top players are within a given industry. Click here to experiment with, for example, our lobbying profile of the pharmaceutical and health products industry.



For permission to reprint for commercial uses, such as textbooks, contact the Center: Feel free to distribute or cite this material, but please credit the Center for Responsive Politics.For permission to reprint for commercial uses, such as textbooks, contact the Center: [email protected]

·

·

·

·

·

·

·

Support Accountability Journalism At OpenSecrets.org we offer in-depth, money-in-politics stories in the public interest. Whether you’re reading about 2020 presidential fundraising, conflicts of interest or “dark money” influence, we produce this content with a small, but dedicated team. Every donation we receive from users like you goes directly into promoting high-quality data analysis and investigative journalism that you can trust. Please support our work and keep this resource free. Thank you. Support OpenSecrets ➜

Read more OpenSecrets News & Analysis: